Sartorius Stedim Biotech (MEX:DIM N) Marketable Securities: MXN581 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:DIM N Sartorius Stedim Biotech SA MEX:DIM N
90 GF Score
Price MXN4,374.26
GF Value MXN5,277.61
! 5 Warning Signs
View Full Analysis

What is Sartorius Stedim Biotech Marketable Securities?

Sartorius Stedim Biotech MEX:DIM N 90 Marketable Securities is MXN581 Mil as of Jun. 2026. GuruFocus rates MEX:DIM N with a GF Score™ of 90/100 and a GF Value™ of MXN5,277.61. The stock has 5 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Sartorius Stedim Biotech's Marketable Securities for the quarter that ended in Jun. 2026 was MXN581 Mil.

Sartorius Stedim Biotech's annual Marketable Securities increased from Dec. 2023 (MXN176 Mil) to Dec. 2024 (MXN216 Mil) but then declined from Dec. 2024 (MXN216 Mil) to Dec. 2025 (MXN171 Mil).

Sartorius Stedim Biotech  (MEX:DIM N) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Sartorius Stedim Biotech Marketable Securities Related Terms

Sartorius Stedim Biotech Marketable Securities Historical Data

* Premium members only.

The historical data trend for Sartorius Stedim Biotech's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sartorius Stedim Biotech Marketable Securities Chart

Sartorius Stedim Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 317.56 0.00 175.85 216.20 170.78

Sartorius Stedim Biotech Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 994.67 850.47 170.78 546.19 580.96
MEX:DIM N
90GF Score
Sartorius Stedim Biotech SA MEX:DIM N
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sartorius Stedim Biotech Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of MXN581 Mil mean?
Sartorius Stedim Biotech (MEX:DIM N) has a Marketable Securities of MXN581 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Sartorius Stedim Biotech and its competitors.
Is Sartorius Stedim Biotech's Marketable Securities too high?
Sartorius Stedim Biotech's current Marketable Securities is MXN581 Mil. Overall, Sartorius Stedim Biotech has a GF Score™ of 90/100, reflecting its overall financial health beyond just this single metric.
How does Sartorius Stedim Biotech's Marketable Securities compare to ISRG and BDX?
Sartorius Stedim Biotech's Marketable Securities of MXN581 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Devices & Instruments company?
A good Marketable Securities depends on the Medical Devices & Instruments industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Sartorius Stedim Biotech and its competitors. Sartorius Stedim Biotech's current Marketable Securities is MXN581 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sartorius Stedim Biotech stock overvalued right now?
Sartorius Stedim Biotech (MEX:DIM N) has a current Marketable Securities of MXN581 Mil. The stock's GF Value™ is MXN5,277.61, compared to a current price of MXN4,374.26 — trading 17.1% below its estimated fair value. The current Marketable Securities is MXN581 Mil. Sartorius Stedim Biotech's overall GF Score™ is 90/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Sartorius Stedim Biotech (MEX:DIM N), the current Marketable Securities is MXN581 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sartorius Stedim Biotech (MEX:DIM N) Overvalued in 2026?

Based on GuruFocus' analysis, Sartorius Stedim Biotech stock appears to be undervalued. The current stock price of MXN4,374.26 is trading 17.1% below its estimated GF Value™ of MXN5,277.61.

Key valuation signals for MEX:DIM N:

  • Marketable Securities: MXN581 Mil
  • GF Value™: MXN5,277.61 vs. price of MXN4,374.26 (17.1% below fair value)
  • GF Score™: 90/100 with 5 warning signs

No single metric tells the full story. See the MEX:DIM N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sartorius Stedim Biotech Business Description

Address Otto-Brenner-Strasse 20, Goettingen, DEU, 37079
Sartorius Stedim Biotech is a leading provider of bioprocessing solutions. It sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs and has a focus on single-use technology. It is a subsidiary of Sartorius AG, which has 71.5% ownership and 83% voting control. The business is geographically diverse, with 35% of sales from the Americas, 42% from Europe, the Middle East, and Africa, 15% from Asia excluding China, and 8% from China.
90GF Score

Get the complete analysis for MEX:DIM N

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN4,374.26
Price
MXN5,277.61
GF Value